While continuing to deny allegations that it illegally marketed and promoted its blockbuster drug Seroquel for unapproved uses, British pharmaceutical company AstraZeneca recently agreed to pay $520 million to settle charges brought against it by the U.S. government.
Seroquel had only been approved by the Food and Drug Administration for use with patients suffering from schizophrenia or bipolar disorder, but the government contended that AstraZeneca promoted the drug to psychiatrists and doctors for patients with other ailments such as post traumatic stress syndrome, depression, ADHD, Alzheimer’s disease, anger management, aggression, and anxiety.
The settlement will be split up among the federal government, the state Medicaid programs and the District of Columbia, with the government’s portion coming in at just over $300 million.
As part of the settlement, AstraZeneca also agreed to enter into a five-year monitoring program to ensure the company’s compliance with U.S. laws. The company will also have to send a letter to doctors about the settlement.
Seroquel had estimated sales of nearly $5 billion in 2009.
For PTSD support based in West Virginia and to read about one courageous West Virginian’s struggles with PTSD and Seroquel, you can visit http://www.lestweforgetptsdsupport.org/default.html.